Teladoc Health, Inc.
TDOC
$6.47
-$0.07-1.07%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.13% | 31.37% | 48.06% | -48.78% | 96.10% |
| Total Depreciation and Amortization | 10.13% | 16.22% | 7.02% | -10.86% | -25.70% |
| Total Amortization of Deferred Charges | -17.18% | -9.11% | 10.16% | 17.92% | 43.99% |
| Total Other Non-Cash Items | -29.80% | -75.02% | -70.02% | -12.33% | -98.12% |
| Change in Net Operating Assets | -99.20% | 12.00% | -61.83% | 66.26% | 240.29% |
| Cash from Operations | -29.28% | -40.22% | 2.14% | -9.90% | 3.10% |
| Capital Expenditure | 26.81% | 39.10% | 57.29% | -42.77% | 33.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.57% | 37.67% | -34.82% | -0.97% | -123.46% |
| Cash from Investing | 30.33% | 70.37% | -15.77% | -56.41% | -115.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.72% | -48.11% | -41.39% | -45.98% | -81.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -99.43% | -1,486.49% | -- |
| Cash from Financing | 100.16% | -418.47% | -46.36% | -614.61% | -14,552.90% |
| Foreign Exchange rate Adjustments | -107.51% | -156.21% | 107.99% | -118.43% | 1,636.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.60% | 71.10% | 0.69% | -42.78% | -897.09% |